Recombinant Human Thyroid Stimulating Hormone
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Recombinant Human Thyroid Stimulating Hormone, covering 2024-05-08 to 2024-05-28. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Advanced/Metastatic Differentiated Thyroid Cancer [NA]